CD4 and graft versus host disease: BTLA recently has been reported to play a role in promoting the survival of activated T cells in mouse models of graft versus host disease (GVHD) [14], [15], and effector T cells during development of colitis in the CD4+CD45RBhigh T cell transfer model [13].